Eye Pharma
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Assessment of the Anti-inflammatory Effects of Norflo Oro in Acute Relapses of HLA-B27 Associated Autoimmune Uveitis (NCT03584724) | Eye Pharma | 2018-12-19 |
Track Eye Pharma automatically
Every clearance here is in the API, with alerts when new ones post.